InvestorsHub Logo
Post# of 251897
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: pcrutch post# 183203

Sunday, 10/26/2014 11:35:50 AM

Sunday, October 26, 2014 11:35:50 AM

Post# of 251897
MDVN/CureTech's anti-PD1 pidilizumab (CT-011)

Back when Teva was in charge, they have focused on hematologic malignancies and also tested the compound in several solid tumors (advanced prostate cancer was one), but don't think any type of breast cancer was one of them.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.